CDC Provides Patient Updates on Coronavirus

Article

The number of coronavirus (COVID-19) cases in the United States continues to grow, which could be extremely stressful for patients with cancer and their loved ones – especially as certain cancer therapies may cause a person to be immunocompromised.

The number of coronavirus (COVID-19) cases in the United States continues to grow, which could be extremely stressful for patients with cancer and their loved ones — especially as certain cancer therapies may cause a person to be immunocompromised.

Dr. Jay C. Butler, the Deputy Director for Infectious Diseases for the Centers for Disease Control and Prevention (CDC), recently hosted a webinar briefing Americans about the disease, as well as the steps they can take to stay safe.

“Be prepared, and don’t be scared,” Butler said, noting that panic does little to help the situation.

Preventing the Spread of COVID-19

However, there are steps that individuals can take that will be helpful in preventing the contraction and/or spread of the virus:

  • Stay 6 feet (or more) apart from others
  • Clean and disinfect surfaces, especially “high-touch” surfaces
  • Wash hands for more than 20 seconds with soap and water. If soap and water is not available, hand sanitizer is a second option

“It appears that the vast majority of infections are transmitted by respiratory droplets,” Butler said. That means that the disease can be given to someone else when an infected person sneezes or coughs around an uninfected person, who then may breathe in the virus particles in the air. “It’s also possible that it can survive on surfaces.”

Butler said that he does not recommend everyone wear a mask, especially since there is a shortage. Those should mainly be reserved for health care professionals.

Additionally, health care institutions are taking steps to mitigate the pandemic, and that might include rearranging appointments and procedures for patients with cancers. “This is how we keep the health care system robust and take care of the people who get sick with COVID-19.”

Next Steps, Treatments, Vaccines

While most people may want the pandemic to end as quickly as possible, Butler actually said that he hopes to spread out the cases of COVID-19 as to not overburden and saturate the health care system.

“In many ways, we want the pandemic to spread out as long as possible. Many people have heard discussions about flattening the curve. This means we want the pandemic to affect as few people as possible at any given time,” Butler said. “When will this end? We’re not sure.”

For now, treatment for coronavirus is symptomatic, Butler said. Researchers are currently working diligently on a vaccine, though it might be a while before it becomes available to the public, which a candidate vaccine trial just starting for humans.

“A vaccine will ultimately be the best way to protect the entire population against this coronavirus,” Butler said. “Unfortunately, this will probably be a year to a year and a half out.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content